UK company reports FDA approval of Phase I/II study for Usher’s syndrome type 1B
According to the UK based company Oxford Biomedica (LSE: OXB), the US FDA has given its approval for the initiation of an open label dose… Read More »UK company reports FDA approval of Phase I/II study for Usher’s syndrome type 1B